Aldose reductase is an enzyme that catalyzes the reduction of glucose to sorbitol in the polyol pathway. Under hyperglycemic conditions seen in diabetes, increased aldose reductase activity leads to sorbitol accumulation which is implicated in diabetic complications like retinopathy. Diabetic retinopathy progresses through mild, moderate, and severe nonproliferative stages before reaching the proliferative stage where new abnormal blood vessels form that can hemorrhage. It is a leading cause of blindness and its treatment involves controlling blood sugar, laser photocoagulation, and vitrectomy.